Ellen Moholt
Spesialsykepleier
ORCID: 0000-0002-4987-4863

Utdanning
- Sykepleierutdanning, Betanien Sykepleierhøyskole 1985 - 1988
- Master i klinisk sykepleier, Høyskolen Gjøvik, NTNU, 2012 - 2015
- NorCRIN – Nasjonalt kurs i studiesykepleie, 2022
- Sertifisert DXA-operatør, 2022
Stilling
- Spesialsykepleier/studiesykepleier
Interessefelt
- Sykepleie til mennesker med revmatisk sykdom
- RA, PsA, SPA
- Osteoporose
- Smerte
E-post
Telefon
22454936
22454298
93031842
Besøksadresse
Diakonhjemmet sykehus
Diakonveien 12
0370 Oslo
Postadresse
Diakohjemmet sykehus
Postboks 23 Vinderen
0319 Oslo
Prosjekter
Prosjektleder:
Siri LillegravenProsjektleder:
Tore K. KvienWP5 - Strategier for digital oppfølging
NOR-Flare
Avstandsoppfølging av pasienter med revmatoid artritt
Prosjektleder:
Anne Therese TveterWP1 - Behandlingsstudier
NOR-Sprint
Oppfølging av nydiagnostiserte pasienter med psoriasisartritt med og uten bildediagnostikk
Prosjektleder:
Siri LillegravenWP1 - Behandlingsstudier
RA-DRUM
Terapeutisk legemiddelmonitorering hos pasienter med revmatoid artritt (RA-DRUM)
Prosjektleder:
Silje Watterdal SyversenPublikasjoner
Publikasjoner hentet fra Nasjonalt vitenarkiv (NVA):
Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial
Kaja Eriksrud Kjørholt, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Hallvard Fremstad
The Lancet Rheumatology
2024
Follow-Up of Patients With Axial Spondyloarthritis in Specialist Health Care With Remote Monitoring and Self-Monitoring Compared With Regular Face-to-Face Follow-Up Visits (the ReMonit Study): Protocol for a Randomized, Controlled Open-Label Noninferiority Trial
Inger Jorid Berg, Anne Therese Tveter, Gunnstein Bakland, Sarah Hakim, Eirik Kristianslund, Siri Lillegraven
JMIR Research Protocols
2023
Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial
Siri Lillegraven, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Åse Lexberg
Annals of the Rheumatic Diseases
2023
Educational readiness among health professionals in rheumatology: low awareness of EULAR offerings and unfamiliarity with the course content as major barriers-results of a EULAR-funded European survey
Valentin Ritschl, Lisa Sperl, Margaret Renn Andrews, Mathilda Björk, Carina Boström, Jeannette Cappon
RMD Open
2023
Endorsement of the OMERACT core domain set for shared decision making interventions in rheumatology trials: Results from a multi-stepped consensus-building approach
Karine Toupin-April, Simon Décary, Maarten de Wit, Alexa Meara, Jennifer L. Barton, Liana Fraenkel
Seminars in Arthritis & Rheumatism
2021
Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients with Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial
Siri Lillegraven, Nina Beate Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Hallvard Fremstad
Journal of the American Medical Association (JAMA)
2021
2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice
Valentin Ritschl, Tanja Stamm, Daniel Aletaha, Hans Bijlsma, Peter Böhm, Răzvan Gabriel Drăgoi
Annals of the Rheumatic Diseases
2020